Apigenin induced MCF-7 cell apoptosis-associated reactive oxygen species

Haihua Bai1, Hua Jin, Fen Yang

  • 1Department of Chemistry and Institute for Nano-Chemistry, Jinan University, Guangzhou, China.

Scanning
|October 21, 2014
PubMed

Insights

Apigenin, a flavonoid, effectively inhibits breast cancer cell growth and induces apoptosis by increasing ROS production. It alters cell morphology and significantly increases the size of cell membrane nanoparticles.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Materials Science

Background:

  • Flavonoids, including apigenin, exhibit potent anti-cancer properties.
  • The effects of apigenin on cancer cell surface characteristics and drug interactions remain underexplored.

Purpose of the Study:

  • To investigate apigenin's impact on human breast cancer cells (MCF-7), focusing on cell surface and membrane structure.
  • To evaluate apigenin's efficacy in inhibiting cancer cell growth, inducing apoptosis, and altering cellular morphology.

Main Methods:

  • MTT assay for cell growth inhibition and cytotoxicity.
  • Flow cytometry for assessing apoptosis and reactive oxygen species (ROS) production.
  • Atomic Force Microscopy (AFM) for analyzing cell and membrane ultrastructure.

Main Results:

  • Apigenin demonstrated dose-dependent growth inhibition in MCF-7 cells with minimal toxicity to normal MCF-10A cells.
  • Apigenin (80 µM) induced significant apoptosis and ROS overproduction in MCF-7 cells.
  • AFM revealed apigenin treatment caused MCF-7 cells to shrink and round, diminishing pseudopodia and increasing cell membrane nanoparticle size from 49 nm to 400 nm.

Conclusions:

  • Apigenin effectively inhibits breast cancer cell growth and induces apoptosis.
  • Apigenin alters MCF-7 cell morphology and significantly impacts cell membrane structure.
  • Apigenin shows potential as a novel therapeutic agent for cancer treatment.

Related Concept Videos

Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
9
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.1K